Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-16-005786
Filing Date
2016-02-16
Accepted
2016-02-16 11:29:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 PIERIS PHARMACEUTICALS, INC. p16-0589sc13g.htm SC 13G 53033
  Complete submission text file 0000902664-16-005786.txt   54642
Mailing Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018
Business Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018 212-295-6200
Lombard Odier Asset Management (USA) Corp (Filed by) CIK: 0001491719 (see all company filings)

EIN.: 061603711 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 603-553-5803
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88917 | Film No.: 161424881
SIC: 8731 Services-Commercial Physical & Biological Research